Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Measles - Overview Measles - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Measles - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Measles - Companies Involved in Therapeutics Development Beijing Minhai Biotechnology Co Ltd Biological E Ltd Cadila Healthcare Ltd Daiichi Sankyo Co Ltd GlaxoSmithKline Plc Panacea Biotec Ltd Sinovac Biotech Ltd VBI Vaccines Inc Vical Inc Measles - Drug Profiles (measles + mumps + rubella + varicella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + mumps + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + mumps + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + mumps + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + rubella + varicella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles + rubella) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress (measles [strain Schwarz] + mumps [strain RIT 4385] + rubella [strain Wistar RA 27/3]) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress ERDRP-0519 - Drug Profile Product Description Mechanism Of Action R&D Progress measles (bivalent) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress measles vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress measles vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress measles vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress VN-0102 - Drug Profile Product Description Mechanism Of Action R&D Progress Measles - Dormant Projects Measles - Product Development Milestones Featured News & Press Releases Aug 21, 2008: Vaxfectin Formulated Measles DNA Vaccine Could Address Unmet Need for Infants Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Measles, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Measles - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2017 Measles - Pipeline by Biological E Ltd, H2 2017 Measles - Pipeline by Cadila Healthcare Ltd, H2 2017 Measles - Pipeline by Daiichi Sankyo Co Ltd, H2 2017 Measles - Pipeline by GlaxoSmithKline Plc, H2 2017 Measles - Pipeline by Panacea Biotec Ltd, H2 2017 Measles - Pipeline by Sinovac Biotech Ltd, H2 2017 Measles - Pipeline by VBI Vaccines Inc, H2 2017 Measles - Pipeline by Vical Inc, H2 2017 Measles - Dormant Projects, H2 2017 List of Figures Number of Products under Development for Measles, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Number of Products by Targets, H2 2017 Number of Products by Stage and Targets, H2 2017 Number of Products by Routes of Administration, H2 2017 Number of Products by Stage and Routes of Administration, H2 2017 Number of Products by Molecule Types, H2 2017 Number of Products by Stage and Molecule Types, H2 2017

Beijing Minhai Biotechnology Co Ltd Biological E Ltd Cadila Healthcare Ltd Daiichi Sankyo Co Ltd GlaxoSmithKline Plc Panacea Biotec Ltd Sinovac Biotech Ltd VBI Vaccines Inc Vical Inc